CSPC Pharmaceutical Group Ltd (1093)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 20 Oct 2026
Key indicators
| Last close | HKD 8.920 |
|---|---|
| 52-week range | 6.387 – 10.720 |
| Return, 1 month / 3 months | +0.8% / +6.1% |
| Return, 1 year / 3 years | −1.5% / +68.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 43 |
| Volatility (1 year) | 47.0% |
| Worst drawdown (1 year) | -36.4% |
| Average daily value traded | 795.30M HKD |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
CSPC Pharmaceutical Group is a pharmaceutical company based in Shijiazhuang, China. It develops, makes and markets finished medicines and bulk pharmaceutical ingredients, with products spanning antibiotics, medicines for heart and blood-vessel conditions, and treatments for cancer. The company supplies hospitals, clinics and distributors, chiefly in its home market, and also exports active ingredients and finished products to customers abroad. Its operations combine research and development with large-scale manufacturing of both generic medicines and pharmaceutical raw materials.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 1093, and the price on this page is in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
CSPC Pharmaceutical Group Ltd (1093) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 8.920 on 20 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 280 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.5% and over the last three months it rose 6.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 80 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 2.9% | ||
| From 52-week high | -14.7% | ||
| Momentum | 70 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 6.1% | ||
| 6-month return | 1.8% | ||
| 12-month return, skipping the last month | -2.3% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 47.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.4% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 795.30M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 37 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.2% |
|---|---|
| 1 month | +0.8% |
| 3 months | +6.1% |
| 6 months | +1.8% |
| 1 year | −1.5% |
| 3 years | +68.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 9.218 / 8.668 |
|---|---|
| Golden / death cross (60 days) | Golden, 33 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.383 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Jun 2026 | HKD 0.1500 |
| 17 Oct 2025 | HKD 0.1400 |
| 4 Jun 2025 | HKD 0.1000 |
| 31 Oct 2024 | HKD 0.1600 |
| 31 May 2024 | HKD 0.1400 |
| 7 Sep 2023 | HKD 0.1400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.